PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4750
0.00 (0.00%)
Oct 1, 2025, 11:59 AM EDT
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 55.72 million as of October 1, 2025. Its market cap has increased by 408.56% in one year.
Market Cap
55.72M
Enterprise Value
47.26M
Revenue
13.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 55.72M, an increase of 2,221.47%. That is a compound annual growth rate of 184.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 55.72M | -12.04% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.53B |
| Green Thumb Industries | 2.35B |
| dentalcorp Holdings | 2.17B |
| Trulieve Cannabis | 1.84B |
| Sienna Senior Living | 1.74B |
| Cronos Group | 1.40B |
| WELL Health Technologies | 1.29B |
| Extendicare | 1.27B |